Skip to content


  • Poster presentation
  • Open Access

P04.14. Acupuncture for carpal tunnel syndrome: a systematic review of randomized controlled trials

  • 1,
  • 1,
  • 2,
  • 1,
  • 3 and
  • 4
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201212 (Suppl 1) :P284

  • Published:


  • Public Health
  • Steroid
  • Internal Medicine
  • Systematic Review
  • Active Control


Acupuncture is a widely used symptomatic treatment for carpal tunnel syndrome (CTS). The objective of this systematic review was to evaluate the evidence of the effectiveness of acupuncture and acupuncture-like treatments for CTS.


Systematic searches were conducted on 11 electronic databases without language restrictions. All randomized controlled trials (RCTs) of acupuncture as a treatment of CTS were included. Methodological quality was assessed using the Cochrane risk of bias tool.


Six RCTs met our inclusion criteria. Their methodological quality was generally low. Two RCTs compared the effectiveness of acupuncture with a sham control. The others used active controls. A meta-analysis of acupuncture versus steroid block therapy favored acupuncture (two studies, n = 144; risk ratio, 1.28; 95% CI, 1.08 to 1.52; p = .005; heterogeneity, I2 = 10%) in terms of responder rate.


Our systematic review and meta-analysis demonstrate that the evidence for acupuncture as a symptomatic therapy of CTS is encouraging but not convincing. The total number of included RCTs and their methodological quality were low. Further rigorous studies are required to establish whether acupuncture has therapeutic value for this indication.

Authors’ Affiliations

Pusan National University, Yangsan, Kyngnam, Republic of Korea
Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
Kyunghee University, Seoul, Republic of Korea
Universtiy of Exeter, Exeter, United Kingdom


© Shim et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.